Positive preliminary results from Genomic Health’s Oncotype DX study in DCIS breast cancer
Positive preliminary results from Genomic Health’s Oncotype DX study in DCIS breast cancer
Genomic Health, Inc. today announced positive preliminary results from a study of Oncotype DX in patients with DCIS by the Eastern Cooperative Oncology Group, a clinical trials cooperative group supported by the National Cancer Institute.
Read more on News-Medical-Net
Categories: Breast Cancer Treatment Tags: breast, cancer, DCIS, From, Genomic, Health's, Oncotype, positive, Preliminary, Results, Study
Genomic Health Announces Positive Results From Large Prostate Cancer Gene Identification Study; Company to Proceed …
Genomic Health Announces Positive Results From Large Prostate Cancer Gene Identification Study; Company to Proceed …
Genomic Health, Inc. today announced the first results of a large prostate cancer study that identified 295 genes strongly associated with clinical recurrence following radical prostatectomy.  Top-line findings from this study, which applied the same RT-PCR technology used in Genomic Health’s Oncotype DX® breast and colon cancer tests, will be presented today at the Society for Urologic …
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: Announces, cancer, company., From, Gene, Genomic, health, identification, Large, positive, Proceed, prostate, Results, Study
Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association
Diffusion Pharmaceuticals presents positive results of TSC study for PAD at American Heart Association
Diffusion Pharmaceuticals LLC today announced positive results of its Phase I/II proof-of-concept study of Trans Sodium Crocetinate (TSC) in patients suffering from walking impairment due to peripheral artery disease (PAD).
Read more on News-Medical-Net
Categories: Breast Cancer Pain Tags: American, Association, Diffusion, heart, Pharmaceuticals, positive, presents, Results, Study
Plexxikon’s PLX4032 shows positive data in patients with metastatic melanoma
Plexxikon’s PLX4032 shows positive data in patients with metastatic melanoma
Plexxikon today announced positive preliminary data from a pivotal Phase 2 clinical trial of PLX4032 (RG7204) in metastatic melanoma, showing significant tumor shrinkage in the majority of patients.
Read more on News-Medical-Net
Categories: Breast Cancer Tumor Tags: Data, Melanoma, Metastatic, Patients, Plexxikon's, PLX4032, positive, Shows
Positive approach is effective tool in breast cancer battle
Positive approach is effective tool in breast cancer battle
“Cancer” is a word no one wants to hear, not from a doctor, a mother, a sister or a friend. It is a word that rips the world out from under us. In the moment it takes to utter those two small syllables, everything changes.
Read more on The Newburyport Current
Manhattan Scientifics Promoting a New Technology to Eliminate False Positive Cancer Analysis
Manhattan Scientifics Promoting a New Technology to Eliminate False Positive Cancer Analysis
ALBUQUERQUE, N.M.—-Manhattan Scientifics, Inc. said today that a July 20th New York Times article titled “Prone to Error: Earliest Steps to Find Cancer” highlights the potential value of the early cancer detection technology developed by Senior Scientific, LLC and licensed by Manhattan Scientifics.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: Analysis, cancer, Eliminate, False, Manhattan, positive, Promoting, Scientifics, technology
BIPOLAR BREAST CANCER SURVIVOR BRCA POSITIVE STILL GOING STRONG!
Bipolar Breast Cancer Survivor BRCA Positive Still going! How does this lady do it, with BRCA, Bipolar and Breast Cancer in remission. Here she is 3 months after stopping Chemo!
Categories: Breast Cancer Survivors Tags: Bipolar, Brca, breast, cancer, going, positive, still, strong, Survivor
Novelos Therapeutics Announces Positive Phase 2 Results in NOV-002 Neoadjuvant Breast Cancer Trial at Sylvester …
Novelos Therapeutics Announces Positive Phase 2 Results in NOV-002 Neoadjuvant Breast Cancer Trial at Sylvester …
NEWTON, Mass.—-Novelos Therapeutics, Inc. , a biopharmaceutical company developing therapeutics to treat cancer and hepatitis, today announced positive results in a Phase 2 trial of NOV-002 in combination with neoadjuvant chemotherapy treatment in patients with stage IIB-IIIC HER-2/neu negative invasive breast cancer, conducted by the Braman Family Breast Cancer Institute at Sylvester …
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Doctors Tags: Announces, breast, cancer, Neoadjuvant, NOV002, Novelos, Phase, positive, Results, Sylvester, Therapeutics', Trial
Nektar Therapeutics Announces Positive Initial Results from Phase 2 Study of NKTR-102 in Metastatic Breast Cancer
Nektar Therapeutics Announces Positive Initial Results from Phase 2 Study of NKTR-102 in Metastatic Breast Cancer
read more
Read more on SYS-CON Media
Categories: Breast Cancer Pain Tags: Announces, breast, cancer, From, initial, Metastatic, Nektar, NKTR102, Phase, positive, Results, Study, Therapeutics'
Woman who has survived cancer twice keeps positive attitude
Woman who has survived cancer twice keeps positive attitude
KELLNER — Jean Irwin made a vague apology for her paper-covered desk.
Read more on Wisconsin Rapids Daily Tribune